{
  "DOI": "10.1007/s00439-021-02399-5",
  "ISSN": [
    "0340-6717",
    "1432-1203"
  ],
  "URL": "http://dx.doi.org/10.1007/s00439-021-02399-5",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003eIn recent years, it has become increasingly apparent that many neurological disorders are underpinned by a genetic aetiology. This has resulted in considerable efforts to develop therapeutic strategies which can treat the disease-causing mutation, either by supplying a functional copy of the mutated gene or editing the genomic sequence. In this review, we will discuss the main genetic strategies which are currently being explored for the treatment of monogenic neurological disorders, as well as some of the challenges they face. In addition, we will address some of the ethical difficulties which may arise.\u003c/jats:p\u003e",
  "alternative-id": [
    "2399"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "30 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "3 November 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "22 November 2021"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "On behalf of all authors, the corresponding author states that there is no conflict of interest."
    }
  ],
  "author": [
    {
      "ORCID": "http://orcid.org/0000-0002-4879-612X",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "FitzPatrick",
      "given": "Laura",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Bird",
      "given": "Adrian",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        11,
        22
      ]
    ],
    "date-time": "2021-11-22T16:06:08Z",
    "timestamp": 1637597168000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        2,
        9
      ]
    ],
    "date-time": "2023-02-09T14:29:47Z",
    "timestamp": 1675952987000
  },
  "funder": [
    {
      "DOI": "10.13039/100004440",
      "award": [
        "091580/Z/10/Z",
        "107930/Z/15/Z",
        "109090"
      ],
      "doi-asserted-by": "publisher",
      "name": "Wellcome Trust"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        7
      ]
    ],
    "date-time": "2024-02-07T09:19:52Z",
    "timestamp": 1707297592498
  },
  "is-referenced-by-count": 2,
  "issn-type": [
    {
      "type": "print",
      "value": "0340-6717"
    },
    {
      "type": "electronic",
      "value": "1432-1203"
    }
  ],
  "issue": "5",
  "issued": {
    "date-parts": [
      [
        2021,
        11,
        22
      ]
    ]
  },
  "journal-issue": {
    "issue": "5",
    "published-print": {
      "date-parts": [
        [
          2022,
          5
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            11,
            22
          ]
        ],
        "date-time": "2021-11-22T00:00:00Z",
        "timestamp": 1637539200000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            11,
            22
          ]
        ],
        "date-time": "2021-11-22T00:00:00Z",
        "timestamp": 1637539200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s00439-021-02399-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s00439-021-02399-5/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s00439-021-02399-5.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1085-1091",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2021,
        11,
        22
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        11,
        22
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        5
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/nbt.4317",
      "author": "F Allen",
      "doi-asserted-by": "publisher",
      "first-page": "64",
      "journal-title": "Nat Biotechnol",
      "key": "2399_CR1",
      "unstructured": "Allen F, Crepaldi L, Alsinet C, Strong AJ, Kleshchevnikov V, De Angeli P, Páleníková P, Khodak A, Kiselev V, Kosicki M, Bassett AR, Harding H, Galanty Y, Muñoz-martínez F, Metzakopian E, Jackson SP, Parts L (2018) Predicting the mutations generated by repair of Cas9-induced double-strand breaks. Nat Biotechnol 37:64–72",
      "volume": "37",
      "year": "2018"
    },
    {
      "DOI": "10.1038/13810",
      "author": "RE Amir",
      "doi-asserted-by": "publisher",
      "first-page": "185",
      "journal-title": "Nat Genet",
      "key": "2399_CR2",
      "unstructured": "Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185–188",
      "volume": "23",
      "year": "1999"
    },
    {
      "DOI": "10.1182/blood-2013-04-497354",
      "author": "XM Anguela",
      "doi-asserted-by": "publisher",
      "first-page": "3283",
      "journal-title": "Blood",
      "key": "2399_CR3",
      "unstructured": "Anguela XM, Sharma R, Doyon Y, Miller JC, Li H, Haurigot V, Rohde ME, Wong SY, Davidson RJ, Zhou S, Gregory PD, Holmes MC, High KA (2013) Robust ZFN-mediated genome editing in adult hemophilic mice. Blood 122:3283–3287",
      "volume": "122",
      "year": "2013"
    },
    {
      "DOI": "10.1038/s41586-019-1711-4",
      "author": "AV Anzalone",
      "doi-asserted-by": "publisher",
      "first-page": "149",
      "journal-title": "Nature",
      "key": "2399_CR4",
      "unstructured": "Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, Chen PJ, Wilson C, Newby GA, Raguram A, Liu DR (2019) Search-and-replace genome editing without double-strand breaks or donor DNA. Nature 576:149–157",
      "volume": "576",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41587-020-0561-9",
      "author": "AV Anzalone",
      "doi-asserted-by": "publisher",
      "first-page": "824",
      "journal-title": "Nat Biotechnol",
      "key": "2399_CR5",
      "unstructured": "Anzalone AV, Koblan LW, Liu DR (2020) Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors. Nat Biotechnol 38:824–844",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41587-020-00793-4",
      "author": "DH Bryant",
      "doi-asserted-by": "publisher",
      "first-page": "691",
      "journal-title": "Nat Biotechnol",
      "key": "2399_CR6",
      "unstructured": "Bryant DH, Bashir A, Sinai S, Jain NK, Ogden PJ, Riley PF, Church GM, Colwell LJ, Kelsic ED (2021) Deep diversification of an AAV capsid protein by machine learning. Nat Biotechnol 39:691–696",
      "volume": "39",
      "year": "2021"
    },
    {
      "DOI": "10.1086/595830",
      "author": "R Calcedo",
      "doi-asserted-by": "publisher",
      "first-page": "381",
      "journal-title": "J Infect Dis",
      "key": "2399_CR7",
      "unstructured": "Calcedo R, Vandenberghe LH, Gao G, Lin J, Wilson JM (2009) Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J Infect Dis 199:381–390",
      "volume": "199",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.tcb.2015.07.009",
      "author": "R Ceccaldi",
      "doi-asserted-by": "publisher",
      "first-page": "52",
      "journal-title": "Trends Cell Biol",
      "key": "2399_CR8",
      "unstructured": "Ceccaldi R, Rondinelli B, D’Andrea AD (2016) Repair pathway choices and consequences at the double-strand break. Trends Cell Biol 26:52–64",
      "volume": "26",
      "year": "2016"
    },
    {
      "DOI": "10.1016/j.molcel.2018.11.031",
      "author": "AM Chakrabarti",
      "doi-asserted-by": "publisher",
      "first-page": "699",
      "journal-title": "Mol Cell",
      "key": "2399_CR9",
      "unstructured": "Chakrabarti AM, Henser-Brownhill T, Monserrat J, Poetsch AR, Luscombe NM, Scaffidi P (2019) Target-specific precision of CRISPR-mediated genome editing. Mol Cell 73:699-713.e6",
      "volume": "73",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nn.4593",
      "author": "KY Chan",
      "doi-asserted-by": "publisher",
      "first-page": "1172",
      "journal-title": "Nat Neurosci",
      "key": "2399_CR10",
      "unstructured": "Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu WL, Sánchez-Guardado L, Lois C, Mazmanian SK, Deverman BE, Gradinaru V (2017) Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci 20:1172–1179",
      "volume": "20",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nrm.2017.48",
      "author": "HHY Chang",
      "doi-asserted-by": "publisher",
      "first-page": "495",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "2399_CR11",
      "unstructured": "Chang HHY, Pannunzio NR, Adachi N, Lieber MR (2017) Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat Rev Mol Cell Biol 18:495–506",
      "volume": "18",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41591-018-0326-x",
      "author": "CT Charlesworth",
      "doi-asserted-by": "publisher",
      "first-page": "249",
      "journal-title": "Nat Med",
      "key": "2399_CR12",
      "unstructured": "Charlesworth CT, Deshpande PS, Dever DP, Camarena J, Lemgart VT, Cromer MK, Vakulskas CA, Collingwood MA, Zhang L, Bode NM, Behlke MA, Dejene B, Cieniewicz B, Romano R, Lesch BJ, Gomez-Ospina N, Mantri S, Pavel-Dinu M, Weinberg KI, Porteus MH (2019) Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat Med 25:249–254",
      "volume": "25",
      "year": "2019"
    },
    {
      "DOI": "10.1038/85906",
      "author": "RZ Chen",
      "doi-asserted-by": "publisher",
      "first-page": "327",
      "journal-title": "Nat Genet",
      "key": "2399_CR13",
      "unstructured": "Chen RZ, Akbarian S, Tudor M, Jaenisch R (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27:327–331",
      "volume": "27",
      "year": "2001"
    },
    {
      "DOI": "10.1186/s13023-018-0786-6",
      "author": "AJ Clarke",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Orphanet J Rare Dis",
      "key": "2399_CR14",
      "unstructured": "Clarke AJ, Abdala Sheikh AP (2018) A perspective on ‘cure’ for Rett syndrome. Orphanet J Rare Dis 13:1–5",
      "volume": "13",
      "year": "2018"
    },
    {
      "DOI": "10.1093/hmg/ddh282",
      "author": "AL Collins",
      "doi-asserted-by": "publisher",
      "first-page": "2679",
      "journal-title": "Hum Mol Genet",
      "key": "2399_CR15",
      "unstructured": "Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, Noebels JL, Sweatt JD, Zoghbi HY (2004) Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13:2679–2689",
      "volume": "13",
      "year": "2004"
    },
    {
      "DOI": "10.1126/science.1231143",
      "author": "L Cong",
      "doi-asserted-by": "publisher",
      "first-page": "819",
      "journal-title": "Science (80-)",
      "key": "2399_CR16",
      "unstructured": "Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex Genome Engineering Using CRISPR/Cas Systems. Science (80-) 339:819–823",
      "volume": "339",
      "year": "2013"
    },
    {
      "DOI": "10.1038/nm.3793",
      "author": "DBT Cox",
      "doi-asserted-by": "publisher",
      "first-page": "121",
      "journal-title": "Nat Med",
      "key": "2399_CR17",
      "unstructured": "Cox DBT, Platt RJ, Zhang F (2015) Therapeutic genome editing: prospects and challenges. Nat Med 21:121–131",
      "volume": "21",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.aaq0180",
      "author": "DBT Cox",
      "doi-asserted-by": "publisher",
      "first-page": "1019",
      "journal-title": "Science (80-)",
      "key": "2399_CR18",
      "unstructured": "Cox DBT, Gootenberg JS, Abudayyeh OO, Franklin B, Kellner MJ, Joung J, Zhang F (2017) RNA editing with CRISPR-Cas13. Science (80-) 358:1019–1027",
      "volume": "358",
      "year": "2017"
    },
    {
      "DOI": "10.1038/d41586-019-00673-1",
      "author": "D Cyranoski",
      "doi-asserted-by": "publisher",
      "first-page": "440",
      "journal-title": "Nature",
      "key": "2399_CR19",
      "unstructured": "Cyranoski D (2019) The CRISPR-baby scandal: what’s next for human gene-editing. Nature 566:440–442",
      "volume": "566",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nbt.3440",
      "author": "BE Deverman",
      "doi-asserted-by": "publisher",
      "first-page": "204",
      "journal-title": "Nat Biotechnol",
      "key": "2399_CR20",
      "unstructured": "Deverman BE, Pravdo PL, Simpson BP, Kumar SR, Chan KY, Banerjee A, Wu WL, Yang B, Huber N, Pasca SP, Gradinaru V (2016) Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol 34:204–209",
      "volume": "34",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41586-020-1978-5",
      "author": "JA Doudna",
      "doi-asserted-by": "publisher",
      "first-page": "229",
      "journal-title": "Nature",
      "key": "2399_CR21",
      "unstructured": "Doudna JA (2020) The promise and challenge of therapeutic genome editing. Nature 578:229–236",
      "volume": "578",
      "year": "2020"
    },
    {
      "DOI": "10.1038/nature14135",
      "author": "TW Fitzgerald",
      "doi-asserted-by": "publisher",
      "first-page": "223",
      "journal-title": "Nature",
      "key": "2399_CR22",
      "unstructured": "Fitzgerald TW, Gerety SS, Jones WD, Van Kogelenberg M, King DA, McRae J, Morley KI, Parthiban V, Al-Turki S, Ambridge K, Barrett DM, Bayzetinova T, Clayton S, Coomber EL, Gribble S, Jones P, Krishnappa N, Mason LE, Middleton A, Miller R et al (2015) Large-scale discovery of novel genetic causes of developmental disorders. Nature 519:223–228",
      "volume": "519",
      "year": "2015"
    },
    {
      "DOI": "10.1038/nbt.1515",
      "author": "KD Foust",
      "doi-asserted-by": "publisher",
      "first-page": "59",
      "journal-title": "Nat Biotechnol",
      "key": "2399_CR23",
      "unstructured": "Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27:59–65",
      "volume": "27",
      "year": "2009"
    },
    {
      "DOI": "10.1126/science.175.4025.949",
      "author": "T Friedmann",
      "doi-asserted-by": "publisher",
      "first-page": "949",
      "journal-title": "Science (80-)",
      "key": "2399_CR24",
      "unstructured": "Friedmann T, Roblin R (1972) Gene therapy for human genetic disease? Science (80-) 175:949–955",
      "volume": "175",
      "year": "1972"
    },
    {
      "DOI": "10.1038/mt.2012.200",
      "author": "KKE Gadalla",
      "doi-asserted-by": "publisher",
      "first-page": "18",
      "journal-title": "Mol Ther",
      "key": "2399_CR25",
      "unstructured": "Gadalla KKE, Bailey MES, Spike RC, Ross PD, Woodard KT, Kalburgi SN, Bachaboina L, Deng JV, West AE, Samulski RJ, Gray SJ, Cobb SR (2013) Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. Mol Ther 21:18–30",
      "volume": "21",
      "year": "2013"
    },
    {
      "DOI": "10.1016/j.omtm.2017.04.007",
      "author": "KKE Gadalla",
      "doi-asserted-by": "publisher",
      "first-page": "180",
      "journal-title": "Mol Ther Methods Clin Dev",
      "key": "2399_CR26",
      "unstructured": "Gadalla KKE, Vudhironarit T, Hector RD, Sinnett S, Bahey NG, Bailey MES, Gray SJ, Cobb SR (2017) Development of a novel AAV gene therapy cassette with improved safety features and efficacy in a mouse model of Rett syndrome. Mol Ther Methods Clin Dev 5:180–190",
      "volume": "5",
      "year": "2017"
    },
    {
      "DOI": "10.1073/pnas.1208507109",
      "author": "G Gasiunas",
      "doi-asserted-by": "publisher",
      "first-page": "2579",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "2399_CR27",
      "unstructured": "Gasiunas G, Barrangou R, Horvath P, Siksnys V (2012) Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc Natl Acad Sci USA 109:2579–2586",
      "volume": "109",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nature24644",
      "author": "NM Gaudelli",
      "doi-asserted-by": "publisher",
      "first-page": "464",
      "journal-title": "Nature",
      "key": "2399_CR28",
      "unstructured": "Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature 551:464–471",
      "volume": "551",
      "year": "2017"
    },
    {
      "DOI": "10.1002/jgm.3015",
      "author": "SL Ginn",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "J Gene Med",
      "key": "2399_CR29",
      "unstructured": "Ginn SL, Amaya AK, Alexander IE, Edelstein M, Abedi MR (2018) Gene therapy clinical trials worldwide to 2017: an update. J Gene Med 20:1–16",
      "volume": "20",
      "year": "2018"
    },
    {
      "DOI": "10.1038/85899",
      "author": "J Guy",
      "doi-asserted-by": "publisher",
      "first-page": "322",
      "journal-title": "Nat Genet",
      "key": "2399_CR30",
      "unstructured": "Guy J, Hendrich B, Holmes M, Martin JE, Bird A (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322–326",
      "volume": "27",
      "year": "2001"
    },
    {
      "DOI": "10.1126/science.1138389",
      "author": "J Guy",
      "doi-asserted-by": "publisher",
      "first-page": "1143",
      "journal-title": "Science (80-)",
      "key": "2399_CR31",
      "unstructured": "Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science (80-) 315:1143–1147",
      "volume": "315",
      "year": "2007"
    },
    {
      "DOI": "10.1038/s41467-019-12449-2",
      "author": "KS Hanlon",
      "doi-asserted-by": "publisher",
      "first-page": "4439",
      "journal-title": "Nat Commun",
      "key": "2399_CR32",
      "unstructured": "Hanlon KS, Kleinstiver BP, Garcia SP, Zaborowski MP, Volak A, Spirig SE, Muller A, Sousa AA, Tsai SQ, Bengtsson NE, Lööv C, Ingelsson M, Chamberlain JS, Corey DP, Aryee MJ, Joung JK, Breakefield XO, Maguire CA, György B (2019) High levels of AAV vector integration into CRISPR-induced DNA breaks. Nat Commun 10:4439",
      "volume": "10",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41587-020-0642-9",
      "author": "C Harrison",
      "doi-asserted-by": "publisher",
      "first-page": "910",
      "journal-title": "Nat Biotechnol",
      "key": "2399_CR33",
      "unstructured": "Harrison C (2020) High-dose AAV gene therapy deaths. Nat Biotechnol 38:910–910",
      "volume": "38",
      "year": "2020"
    },
    {
      "DOI": "10.1089/hum.2018.015",
      "author": "C Hinderer",
      "doi-asserted-by": "publisher",
      "first-page": "285",
      "journal-title": "Hum Gene Ther",
      "key": "2399_CR34",
      "unstructured": "Hinderer C, Katz N, Buza EL, Dyer C, Goode T, Bell P, Richman LK, Wilson JM (2018) Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum Gene Ther 29:285–298",
      "volume": "29",
      "year": "2018"
    },
    {
      "DOI": "10.1016/j.ymthe.2018.01.018",
      "author": "J Hordeaux",
      "doi-asserted-by": "publisher",
      "first-page": "664",
      "journal-title": "Mol Ther",
      "key": "2399_CR35",
      "unstructured": "Hordeaux J, Wang Q, Katz N, Buza EL, Bell P, Wilson JM (2018) The neurotropic properties of AAV-PHP.B are limited to C57BL/6J mice. Mol Ther 26:664–668",
      "volume": "26",
      "year": "2018"
    },
    {
      "DOI": "10.1371/journal.pone.0225206",
      "author": "Q Huang",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "PLoS ONE",
      "key": "2399_CR36",
      "unstructured": "Huang Q, Chan KY, Tobey IG, Chan YA, Poterba T, Boutros CL, Balazs AB, Daneman R, Bloom JM, Seed C, Deverman BE (2019) Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids. PLoS ONE 14:1–17",
      "volume": "14",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.neuron.2019.02.017",
      "author": "E Hudry",
      "doi-asserted-by": "publisher",
      "first-page": "839",
      "journal-title": "Neuron",
      "key": "2399_CR37",
      "unstructured": "Hudry E, Vandenberghe LH (2019) Therapeutic AAV gene transfer to the nervous system: a clinical reality. Neuron 101:839–862",
      "volume": "101",
      "year": "2019"
    },
    {
      "DOI": "10.3390/ijms161024751",
      "author": "K Ishida",
      "doi-asserted-by": "publisher",
      "first-page": "24751",
      "journal-title": "Int J Mol Sci",
      "key": "2399_CR38",
      "unstructured": "Ishida K, Gee P, Hotta A (2015) Minimizing off-target mutagenesis risks caused by programmable nucleases. Int J Mol Sci 16:24751–24771",
      "volume": "16",
      "year": "2015"
    },
    {
      "DOI": "10.1126/science.1225829",
      "author": "M Jinek",
      "doi-asserted-by": "publisher",
      "first-page": "816",
      "journal-title": "Science",
      "key": "2399_CR39",
      "unstructured": "Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816–821",
      "volume": "337",
      "year": "2012"
    },
    {
      "DOI": "10.1038/nrg2971",
      "author": "MA Kay",
      "doi-asserted-by": "publisher",
      "first-page": "316",
      "journal-title": "Nat Rev Genet",
      "key": "2399_CR40",
      "unstructured": "Kay MA (2011) State-of-the-art gene-based therapies: the road ahead. Nat Rev Genet 12:316–328",
      "volume": "12",
      "year": "2011"
    },
    {
      "DOI": "10.3389/fnmol.2019.00109",
      "author": "N Khatri",
      "doi-asserted-by": "publisher",
      "first-page": "1",
      "journal-title": "Front Mol Neurosci",
      "key": "2399_CR41",
      "unstructured": "Khatri N, Man HY (2019) The autism and Angelman syndrome protein Ube3A/E6AP: The gene, E3 ligase ubiquitination targets and neurobiological functions. Front Mol Neurosci 12:1–12",
      "volume": "12",
      "year": "2019"
    },
    {
      "DOI": "10.1038/nature17946",
      "author": "AC Komor",
      "doi-asserted-by": "publisher",
      "first-page": "420",
      "journal-title": "Nature",
      "key": "2399_CR42",
      "unstructured": "Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533:420–424",
      "volume": "533",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41551-018-0252-8",
      "author": "B Lee",
      "doi-asserted-by": "publisher",
      "first-page": "497",
      "journal-title": "Nat Biomed Eng",
      "key": "2399_CR43",
      "unstructured": "Lee B, Lee K, Panda S, Gonzales-Rojas R, Chong A, Bugay V, Park HM, Brenner R, Murthy N, Lee HY (2018) Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours. Nat Biomed Eng 2:497–507",
      "volume": "2",
      "year": "2018"
    },
    {
      "DOI": "10.1038/s41551-019-0501-5",
      "author": "JM Levy",
      "doi-asserted-by": "publisher",
      "first-page": "97",
      "journal-title": "Nat Biomed Eng",
      "key": "2399_CR44",
      "unstructured": "Levy JM, Yeh WH, Pendse N, Davis JR, Hennessey E, Butcher R, Koblan LW, Comander J, Liu Q, Liu DR (2020) Cytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated viruses. Nat Biomed Eng 4:97–110",
      "volume": "4",
      "year": "2020"
    },
    {
      "DOI": "10.1073/pnas.0401626101",
      "author": "S Luikenhuis",
      "doi-asserted-by": "publisher",
      "first-page": "6033",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "2399_CR45",
      "unstructured": "Luikenhuis S, Giacometti E, Beard CF, Jaenisch R (2004) Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc Natl Acad Sci USA 101:6033–6038",
      "volume": "101",
      "year": "2004"
    },
    {
      "DOI": "10.1016/j.dnarep.2008.06.018",
      "author": "Z Mao",
      "doi-asserted-by": "publisher",
      "first-page": "1765",
      "journal-title": "DNA Repair (amst)",
      "key": "2399_CR46",
      "unstructured": "Mao Z, Bozzella M, Seluanov A, Gorbunova V (2008) Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair (amst) 7:1765–1771",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1038/nature21062",
      "author": "JF McRae",
      "doi-asserted-by": "publisher",
      "first-page": "433",
      "journal-title": "Nature",
      "key": "2399_CR47",
      "unstructured": "McRae JF, Clayton S, Fitzgerald TW, Kaplanis J, Prigmore E, Rajan D, Sifrim A, Aitken S, Akawi N, Alvi M, Ambridge K, Barrett DM, Bayzetinova T, Jones P, Jones WD, King D, Krishnappa N, Mason LE, Singh T, Tivey AR et al (2017) Prevalence and architecture of de novo mutations in developmental disorders. Nature 542:433–438",
      "volume": "542",
      "year": "2017"
    },
    {
      "DOI": "10.1056/NEJMoa1706198",
      "author": "JR Mendell",
      "doi-asserted-by": "publisher",
      "first-page": "1713",
      "journal-title": "N Engl J Med",
      "key": "2399_CR48",
      "unstructured": "Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, Lowes L, Alfano L, Berry K, Church K, Kissel JT, Nagendran S, L’Italien J, Sproule DM, Wells C, Cardenas JA, Heitzer MD, Kaspar A, Corcoran S, Braun L et al (2017) Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med 377:1713–1722",
      "volume": "377",
      "year": "2017"
    },
    {
      "DOI": "10.1128/MCB.23.10.3550-3557.2003",
      "author": "DG Miller",
      "doi-asserted-by": "publisher",
      "first-page": "3550",
      "journal-title": "Mol Cell Biol",
      "key": "2399_CR49",
      "unstructured": "Miller DG, Petek LM, Russell DW (2003) Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks. Mol Cell Biol 23:3550–3557",
      "volume": "23",
      "year": "2003"
    },
    {
      "DOI": "10.1038/ng1380",
      "author": "DG Miller",
      "doi-asserted-by": "publisher",
      "first-page": "767",
      "journal-title": "Nat Genet",
      "key": "2399_CR50",
      "unstructured": "Miller DG, Petek LM, Russell DW (2004) Adeno-associated virus vectors integrate at chromosome breakage sites. Nat Genet 36:767–773",
      "volume": "36",
      "year": "2004"
    },
    {
      "DOI": "10.1182/blood-2013-01-306647",
      "author": "F Mingozzi",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "Blood",
      "key": "2399_CR51",
      "unstructured": "Mingozzi F, High KA (2013) Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood 122:23–36",
      "volume": "122",
      "year": "2013"
    },
    {
      "DOI": "10.1089/hum.2011.220",
      "author": "G Mittermeyer",
      "doi-asserted-by": "publisher",
      "first-page": "377",
      "journal-title": "Hum Gene Ther",
      "key": "2399_CR52",
      "unstructured": "Mittermeyer G, Christine CW, Rosenbluth KH, Baker SL, Starr P, Larson P, Kaplan PL, Forsayeth J, Aminoff MJ, Bankiewicz KS (2011) Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson’s disease. Hum Gene Ther 23:377–381",
      "volume": "23",
      "year": "2011"
    },
    {
      "DOI": "10.1073/pnas.1306243110",
      "author": "MF Montiel-Gonzalez",
      "doi-asserted-by": "publisher",
      "first-page": "18285",
      "journal-title": "Proc Natl Acad Sci USA",
      "key": "2399_CR53",
      "unstructured": "Montiel-Gonzalez MF, Vallecillo-Viejo I, Yudowski GA, Rosenthal JJC (2013) Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc Natl Acad Sci USA 110:18285–18290",
      "volume": "110",
      "year": "2013"
    },
    {
      "author": "National Academy of Sciences",
      "key": "2399_CR54",
      "unstructured": "National Academy of Sciences (2020) Heritable human genome editing. National Academies Press, Washington D.C.",
      "volume-title": "Heritable human genome editing",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41591-019-0344-3",
      "author": "CE Nelson",
      "doi-asserted-by": "publisher",
      "first-page": "427",
      "journal-title": "Nat Med",
      "key": "2399_CR55",
      "unstructured": "Nelson CE, Wu Y, Gemberling MP, Oliver ML, Waller MA, Bohning JD, Robinson-Hamm JN, Bulaklak K, Castellanos Rivera RM, Collier JH, Asokan A, Gersbach CA (2019) Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nat Med 25:427–432",
      "volume": "25",
      "year": "2019"
    },
    {
      "key": "2399_CR56",
      "unstructured": "Nuffield Council on Bioethics (2016) Genome editing and human reproduction: social and ethical issues"
    },
    {
      "DOI": "10.1038/nature17664",
      "author": "D Paquet",
      "doi-asserted-by": "publisher",
      "first-page": "125",
      "journal-title": "Nature",
      "key": "2399_CR57",
      "unstructured": "Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KM, Gregg A, Noggle S, Tessier-Lavigne M (2016) Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature 533:125–129",
      "volume": "533",
      "year": "2016"
    },
    {
      "DOI": "10.3390/brainsci10020119",
      "author": "BA Perez",
      "doi-asserted-by": "publisher",
      "first-page": "119",
      "journal-title": "Brain Sci",
      "key": "2399_CR58",
      "unstructured": "Perez BA, Shutterly A, Chan YK, Byrne BJ, Corti M (2020) Management of neuroinflammatory responses to AAV-mediated gene therapies for neurodegenerative diseases. Brain Sci 10:119",
      "volume": "10",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41573-020-0084-6",
      "author": "EM Porto",
      "doi-asserted-by": "publisher",
      "first-page": "839",
      "journal-title": "Nat Rev Drug Discov",
      "key": "2399_CR59",
      "unstructured": "Porto EM, Komor AC, Slaymaker IM, Yeo GW (2020) Base editing: advances and therapeutic opportunities. Nat Rev Drug Discov 19:839–859",
      "volume": "19",
      "year": "2020"
    },
    {
      "DOI": "10.1046/j.0022-3042.2002.00776.x",
      "author": "K Ren",
      "doi-asserted-by": "publisher",
      "first-page": "949",
      "journal-title": "J Neurochem",
      "key": "2399_CR60",
      "unstructured": "Ren K, Peña De Ortiz S (2002) Non-homologous DNA end joining in the mature rat brain. J Neurochem 80:949–959",
      "volume": "80",
      "year": "2002"
    },
    {
      "DOI": "10.1093/brain/aws096",
      "author": "L Robinson",
      "doi-asserted-by": "publisher",
      "first-page": "2699",
      "journal-title": "Brain",
      "key": "2399_CR61",
      "unstructured": "Robinson L, Guy J, McKay L, Brockett E, Spike RC, Selfridge J, De Sousa D, Merusi C, Riedel G, Bird A, Cobb SR (2012) Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome. Brain 135:2699–2710",
      "volume": "135",
      "year": "2012"
    },
    {
      "DOI": "10.1128/MCB.23.16.5706-5715.2003",
      "author": "K Rothkamm",
      "doi-asserted-by": "publisher",
      "first-page": "5706",
      "journal-title": "Mol Cell Biol",
      "key": "2399_CR62",
      "unstructured": "Rothkamm K, Krüger I, Thompson LH, Kru I, Lo M (2003) Pathways of DNA double-strand break repair during the mammalian cell cycle pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 23:5706–5715",
      "volume": "23",
      "year": "2003"
    },
    {
      "DOI": "10.1089/humc.2017.010",
      "author": "Y Sehara",
      "doi-asserted-by": "publisher",
      "first-page": "74",
      "journal-title": "Hum Gene Ther Clin Dev",
      "key": "2399_CR63",
      "unstructured": "Sehara Y, Fujimoto KI, Ikeguchi K, Katakai Y, Ono F, Takino N, Ito M, Ozawa K, Muramatsu SI (2017) Persistent expression of dopamine-synthesizing enzymes 15 years after gene transfer in a primate model of Parkinson’s disease. Hum Gene Ther Clin Dev 28:74–79",
      "volume": "28",
      "year": "2017"
    },
    {
      "DOI": "10.1038/s41586-018-0686-x",
      "author": "MW Shen",
      "doi-asserted-by": "publisher",
      "first-page": "646",
      "journal-title": "Nature",
      "key": "2399_CR64",
      "unstructured": "Shen MW, Arbab M, Hsu JY, Worstell D, Culbertson SJ, Krabbe O, Cassa CA, Liu DR, Gifford DK, Sherwood RI (2018) Predictable and precise template-free CRISPR editing of pathogenic variants. Nature 563:646–651",
      "volume": "563",
      "year": "2018"
    },
    {
      "DOI": "10.1172/JCI80554",
      "author": "S Silva-Santos",
      "doi-asserted-by": "publisher",
      "first-page": "2069",
      "journal-title": "J Clin Invest",
      "key": "2399_CR65",
      "unstructured": "Silva-Santos S, Van Woerden GM, Bruinsma CF, Mientjes E, Jolfaei MA, Distel B, Kushner SA, Elgersma Y (2015) Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model. J Clin Invest 125:2069–2076",
      "volume": "125",
      "year": "2015"
    },
    {
      "DOI": "10.1016/j.celrep.2020.107878",
      "author": "JR Sinnamon",
      "doi-asserted-by": "publisher",
      "first-page": "107878",
      "journal-title": "Cell Rep",
      "key": "2399_CR67",
      "unstructured": "Sinnamon JR, Kim SY, Fisk JR, Song Z, Nakai H, Jeng S, McWeeney SK, Mandel G (2020) In vivo repair of a protein underlying a neurological disorder by programmable RNA editing. Cell Rep 32:107878",
      "volume": "32",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.omtm.2017.04.006",
      "author": "SE Sinnett",
      "doi-asserted-by": "publisher",
      "first-page": "106",
      "journal-title": "Mol Ther Methods Clin Dev",
      "key": "2399_CR68",
      "unstructured": "Sinnett SE, Hector RD, Gadalla KKE, Heindel C, Chen D, Zaric V, Bailey MES, Cobb SR, Gray SJ (2017) Improved MECP2 gene therapy extends the survival of MeCP2-null mice without apparent toxicity after intracisternal delivery. Mol Ther Methods Clin Dev 5:106–115",
      "volume": "5",
      "year": "2017"
    },
    {
      "DOI": "10.1038/nbt.3806",
      "author": "BT Staahl",
      "doi-asserted-by": "publisher",
      "first-page": "431",
      "journal-title": "Nat Biotechnol",
      "key": "2399_CR69",
      "unstructured": "Staahl BT, Benekareddy M, Coulon-Bainier C, Banfal AA, Floor SN, Sabo JK, Urnes C, Munares GA, Ghosh A, Doudna JA (2017) Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes. Nat Biotechnol 35:431–434",
      "volume": "35",
      "year": "2017"
    },
    {
      "DOI": "10.1086/444549",
      "author": "H Van Esch",
      "doi-asserted-by": "publisher",
      "first-page": "442",
      "journal-title": "Am J Hum Genet",
      "key": "2399_CR70",
      "unstructured": "Van Esch H, Bauters M, Ignatius J, Jansen M, Raynaud M, Hollanders K, Lugtenberg D, Bienvenu T, Jensen LR, Gecz J, Moraine C, Marynen P, Fryns J-P, Froyen G (2005) Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 77:442–453",
      "volume": "77",
      "year": "2005"
    },
    {
      "DOI": "10.1016/j.molcel.2016.06.037",
      "author": "M van Overbeek",
      "doi-asserted-by": "publisher",
      "first-page": "633",
      "journal-title": "Mol Cell",
      "key": "2399_CR71",
      "unstructured": "van Overbeek M, Capurso D, Carter MM, Thompson MS, Frias E, Russ C, Reece-Hoyes JS, Nye C, Gradia S, Vidal B, Zheng J, Hoffman GR, Fuller CK, May AP (2016) DNA repair profiling reveals nonrandom outcomes at Cas9-mediated breaks. Mol Cell 63:633–646",
      "volume": "63",
      "year": "2016"
    },
    {
      "DOI": "10.1038/s41591-018-0204-6",
      "author": "DL Wagner",
      "doi-asserted-by": "publisher",
      "first-page": "242",
      "journal-title": "Nat Med",
      "key": "2399_CR72",
      "unstructured": "Wagner DL, Amini L, Wendering DJ, Burkhardt LM, Akyüz L, Reinke P, Volk HD, Schmueck-Henneresse M (2019) High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med 25:242–248",
      "volume": "25",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.cell.2020.03.023",
      "author": "D Wang",
      "doi-asserted-by": "publisher",
      "first-page": "136",
      "journal-title": "Cell",
      "key": "2399_CR73",
      "unstructured": "Wang D, Zhang F, Gao G (2020) CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors. Cell 181:136–150",
      "volume": "181",
      "year": "2020"
    },
    {
      "key": "2399_CR74",
      "unstructured": "WHO (2021) WHO Expert Advisory Committee on Developing Global Standards for Governance and Oversight of Human Genome Editing. Human Genome Editing: recommendations"
    },
    {
      "DOI": "10.1089/hum.2020.182",
      "author": "JM Wilson",
      "doi-asserted-by": "publisher",
      "first-page": "695",
      "journal-title": "Hum Gene Ther",
      "key": "2399_CR75",
      "unstructured": "Wilson JM, Flotte TR (2020) Moving forward after two deaths in a gene therapy trial of myotubular myopathy. Hum Gene Ther 31:695–696",
      "volume": "31",
      "year": "2020"
    },
    {
      "DOI": "10.1038/s41392-020-00451-w",
      "author": "C Zhuo",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "Signal Transduct Target Ther",
      "key": "2399_CR76",
      "unstructured": "Zhuo C, Zhang J, Lee JH, Jiao J, Cheng D, Liu L, Kim HW, Tao Y, Li M (2021) Spatiotemporal control of CRISPR/Cas9 gene editing. Signal Transduct Target Ther 6:1–18",
      "volume": "6",
      "year": "2021"
    },
    {
      "DOI": "10.1038/nbt.3081",
      "author": "JA Zuris",
      "doi-asserted-by": "publisher",
      "first-page": "73",
      "journal-title": "Nat Biotechnol",
      "key": "2399_CR77",
      "unstructured": "Zuris JA, Thompson DB, Shu Y, Guilinger JP, Bessen JL, Hu JH, Maeder ML, Joung JK, Chen Z-Y, Liu DR (2014) Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat Biotechnol 33:73–80",
      "volume": "33",
      "year": "2014"
    }
  ],
  "reference-count": 76,
  "references-count": 76,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s00439-021-02399-5"
    }
  },
  "score": 0,
  "short-container-title": [
    "Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Genetic therapies for neurological disorders"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "141"
}